tirzepatide use in pregnancy discontinue before conception how long label These highlights do not include all the information Weight Loss Medication and Pregnancy:

Leaders in Connecticut, facing a $290 million Medicaid deficit, have moved away from an initial proposal to cover GLP-1s for obesity, and are now requiring patients to get a Type 2 diabetes diagnosis to qualify for coverage

For example, in the case of alcohol withdrawal, seizures and delirium tremens (hallucinations, tremors, and more) can be fatal

Data are required to better inform when to select a GLP-1 RA and/or an SGLT2i in the setting of CVD but without HF or CKD, and to fully validate the recommendation for combination therapy in those at high risk who do not meet glycaemic targets

The arrival of highly effective weight loss pharmacotherapies marked an inflection point for the obesity market